* Free cash flow = OCF − net investing outflow (the filings carry no standalone capex line).
Dividends declared (per SOCE filings): FY2020 0 · FY2021 1,150 · FY2022 568 — 3-yr total 1,718
Operates in Healthcare Services — Other healthcare services. Per the activity note to the FY2022 annual report, the company provides specialized medical practice services and pharmaceutical wholesale trade. Registered on 5 November 2018.
| Line item | 2020 | 2021 | 2022 | CAGR |
|---|---|---|---|---|
| Net Cash from Operating Activities | 64 | 1,405 | 214 | nmf |
| Net Cash used in Investing Activities | 0 | 1,150 | 464 | -59.6% |
| Free Cash Flow (OCF − Capex proxy) | 64 | 255 | 250 | +97.9% |
| Net Cash from Financing Activities | 66 | 0 | 0 | |
| Net Change in Cash (before FX) | 2 | 255 | 250 | nmf |
| Net Change in Cash (incl. FX) | 2 | 255 | 250 | nmf |
| Cash at Beginning of Year | 0 | 2 | 257 | nmf |
| Cash at End of Year | 2 | 257 | 7 | +99.4% |
Shareholders, directors and group links from the companyinfo.ge public register — as filed, so stakes need not sum to 100% where a holding is undisclosed.
Ownership & directors from companyinfo.ge (public corporate registry).
Ranked by how close each latest revenue is to this one — not a curated comp set. Open this set in Compare →